Nutex Health (NASDAQ:NUTX) Stock Price Up 9.1% – Time to Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s stock price shot up 9.1% during trading on Wednesday . The stock traded as high as $184.40 and last traded at $186.4720. 125,047 shares changed hands during trading, a decline of 30% from the average session volume of 178,992 shares. The stock had previously closed at $170.89.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on NUTX. Lake Street Capital started coverage on Nutex Health in a report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 target price on the stock. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They set a “buy” rating and a $290.00 price target on the stock. Zacks Research raised Nutex Health to a “hold” rating in a report on Monday. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $243.33.

Nutex Health Stock Up 11.1%

The stock has a market cap of $1.31 billion, a P/E ratio of 14.67 and a beta of 0.26. The firm has a 50 day simple moving average of $131.86 and a 200-day simple moving average of $129.94. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The business had revenue of $216.49 million for the quarter, compared to analysts’ expectations of $227.80 million. On average, equities research analysts forecast that Nutex Health Inc. will post 22.72 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Nutex Health

Hedge funds have recently bought and sold shares of the stock. Pertento Partners LLP bought a new stake in shares of Nutex Health in the third quarter valued at about $27,940,000. Topline Capital Management LLC raised its stake in Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after purchasing an additional 247,436 shares in the last quarter. Millennium Management LLC raised its stake in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after purchasing an additional 61,308 shares in the last quarter. Empowered Funds LLC bought a new stake in Nutex Health in the 1st quarter valued at about $3,084,000. Finally, SG Americas Securities LLC grew its position in shares of Nutex Health by 3,232.6% during the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after purchasing an additional 29,449 shares in the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.